Women in Immunology

New for 2020, as part of our Immuno Series we are delighted to announce the Women in Immunology symposium. This session is designed to provide a platform for female speakers to share their research and experience, highlighting the ground-breaking work being completed by women in immunology.

Confirmed Speakers

Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.

The following were confirmed speakers for the 2020 Series.

Alex Cao
Executive Director, Head of Clinical Biomarkers, Translational Oncology
MSD
Ali Mohamed
Vice President, CMC
Immatics
Ali Roghanian
Lecturer in Cancer Immunotherapy
University of Southampton
Andrew Exley
Medical Assessor, Biologicals and Biotechnology Unit
MHRA
Barbara Joyce-Shaikh
Associate Principal Scientist
MSD
Bryan Glaser
Vice President of Business Development
Invenra
Celine Adessi
Senior Director, Group Head, Oncology, Clinical Safety
F. Hoffmann-La Roche Ltd
David Dornan
Senior Vice President and Head of Research
Bolt Bio
David Wraith
Professor of Immunology
Institute of Immunolgy & Immunology
Dorothee Bourges
Lab Head Pharmacology/Immuno-Oncology
Sanofi
Douglas Widman
Associate Director of R&D Program Management
Karyopharm Therapeutics Inc.
Elena Menietti
Scientist
F. Hoffmann-La Roche Ltd
Eleni Vritzali
Medical Director, Global Development Immunology and Transplantation
Novartis
Farhat Syed
Associate Director Precision Medicine
AstraZeneca
Geert Mudde
Chief Scientific Officer & Founder
OncoQR ML, S-TARget Therapeutics GmbH and TYG Oncology Ltd.
Graham Pockley
Director & Professor of Immunobiology
Nottingham Trent University
Guido Wollmann
Chief Scientific Officer
Immutep
James Legg
Senior Vice President Research
Crescendo Biologics
Jens Kringelum
Director Genomic Immuno-Oncology
Evaxion Biotech
Jochen Strizker
Senior Vice President Immunotherapy
Themis Bioscience GmbH
John Maher
Professor
King's College London
Jonathan Pachter
Chief Scientific Officer
Verastem
Lindy Durrant
Chief Scientific Officer
Scancell
Marc van Dijk
Vice President Platform Technology
AgenTus Therapeutics
Marek Stastny
Senior Scientific Advisor
Bristol-Myers Squibb
Mari Suominen
Research Director
Pharmatest Services Ltd
Maria Amann
Principal Scientist
F. Hoffmann-La Roche Ltd
Mario Ehlers
Executive Director, Head of Early Clinical Development, Immunology
Boehringer Ingelheim
Masha Poyurovsky
Vice President, Discovery Biology
Kadmon Research Institute
Matthew Robinson
Vice President Translational Biology
Microbiotica
Matthew Sleeman
Executive Director, Immunology & Inflammation
Regeneron Pharmaceuticals
Matthias Brock
Group Leader Pharmacology
Numab
Omid Vafa
Chief Business Officer
Teneo Bio
Pakeeza Sayyed
Principal Clinical Scientist
F. Hoffmann-La Roche Ltd
Pelin Candarlioglu
Investigator - Bioengineer/Cell Biologist
GlaxoSmithKline
Peter Schafer
Bristol-Myers Squibb
Peter Weber
Director
Immunocore
Rajita Pappu
Senior Scientist, Immunology Discovery
Genentech
Rinse Klooster
Associate Director
Merus N.V.
Russell LaMontagne
Chief Executive Officer
Boston Immune Technologies and Therapeutics
Saso Cemerski
Senior Director, Translational Immunology
CUE BioPharm
Shahram Lavasani
President & Chief Executive Officer
Immune Bio AB
Shruthi Bharadwaj
Senior Scientist, Oncology Precision Medicine
Novartis
Sonia Feau
Associate Director Immunology
Oncorus
Stuart Farrow
Director of Biology, Therapeutic Discovery Laboratories
Cancer Research UK
Tauseef Butt
President & Chief Executive Officer
Progenra

Advancements In Spatial Genomics Research - Oncology Focus

Live Webinar taking place
Thursday 29th October 2020, 15:00 - 16:00 GMT

Register for the webinar that includes three short presentations on Spatial Biology and one narrated poster. The illustrious presenters will share interesting insights on how to uncover biomarkers in situ and how to deconvolute scRNA data and spatial profiling results in situ.